VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
8 hedge funds and large institutions have $11.3M invested in VIVEVE MED INC in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$3.8M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$3.03M |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$2.92M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$1.72M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.3M |
Top Sellers
VIVE Hedge Fund Activity: Q2 2016 in Review
8 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2016, worth a combined $11.3M.
Buyers outnumbered sellers: 8 funds opened new VIVE positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $3.8M.
- 8 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $11.3M of VIVEVE MED INC stock for Q2 2016.
- 8 funds opened new VIVEVE MED INC positions in Q2 2016 and 0 closed out, a net change of +8 holders.
- The largest VIVEVE MED INC buyer in Q2 2016 was RTW Investments, an estimated $3.8M added.
Based on aggregated 13F filings for Q2 2016.